Tariffs Simulator (BETA)
Chat OEC
Company Explorer
Tree map
Stacked
Network
Map
Scatter
Exports In 2023, Italy exported $9.18B in Vaccines, blood, antisera, toxins and cultures, making it the 10th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most exported product in Italy. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Italy are: United States ($2.23B), Netherlands ($1.52B), Germany ($752M), Poland ($680M), and Belgium ($655M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Italy between 2022 and 2023 were United States ($761M), Netherlands ($466M), and Austria ($120M).
Imports In 2023, Italy imported $11B in Vaccines, blood, antisera, toxins and cultures, becoming the 9th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Italy. Italy imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($2.48B), Belgium ($2.13B), Netherlands ($1.47B), United States ($1.09B), and South Korea ($810M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Italy between 2022 and 2023 were Switzerland ($183M), Ireland ($178M), and Netherlands ($147M).
